Startseite et-2862

Edgar V. Lerma 🇵🇭 on X: @JochenReiser @Kidney_Int @goKDIGO See this study (ca. 2014) by @raja_1980 from @NDTsocial In patients with FSGS who had complete remission (CR), TAC dose was reduced to

Von einem Mystery-Man-Autor
Last updated 13 Juni 2024
Edgar V. Lerma 🇵🇭 on X: @JochenReiser @Kidney_Int @goKDIGO See this study (ca. 2014) by @raja_1980 from @NDTsocial In patients with FSGS who had complete remission (CR), TAC dose was reduced to
Edgar V. Lerma 🇵🇭 on X: @JochenReiser @Kidney_Int @goKDIGO See this study (ca. 2014) by @raja_1980 from @NDTsocial In patients with FSGS who had complete remission (CR), TAC dose was reduced to
Edgar V. Lerma 🇵🇭 on X: Studies have demonstrated that patients
Edgar V. Lerma 🇵🇭 on X: @JochenReiser @Kidney_Int @goKDIGO See this study (ca. 2014) by @raja_1980 from @NDTsocial In patients with FSGS who had complete remission (CR), TAC dose was reduced to
Edgar V. Lerma 🇵🇭 on X: Membranous Nephropathy: 2 important
Edgar V. Lerma 🇵🇭 on X: @JochenReiser @Kidney_Int @goKDIGO See this study (ca. 2014) by @raja_1980 from @NDTsocial In patients with FSGS who had complete remission (CR), TAC dose was reduced to
Edgar V. Lerma 🇵🇭 ಮೇಲೆ X: CKD-aP (CKD associated pruritus
Edgar V. Lerma 🇵🇭 on X: @JochenReiser @Kidney_Int @goKDIGO See this study (ca. 2014) by @raja_1980 from @NDTsocial In patients with FSGS who had complete remission (CR), TAC dose was reduced to
Edgar Lerma on LinkedIn: #kdigoadpkd #nephpearls
Edgar V. Lerma 🇵🇭 on X: @JochenReiser @Kidney_Int @goKDIGO See this study (ca. 2014) by @raja_1980 from @NDTsocial In patients with FSGS who had complete remission (CR), TAC dose was reduced to
Edgar V. Lerma 🇵🇭 on X: .@goKDIGO 2021 Clinical Practice
Edgar V. Lerma 🇵🇭 on X: @JochenReiser @Kidney_Int @goKDIGO See this study (ca. 2014) by @raja_1980 from @NDTsocial In patients with FSGS who had complete remission (CR), TAC dose was reduced to
Edgar V. Lerma 🇵🇭 ಮೇಲೆ X: CKD-aP (CKD associated pruritus
Edgar V. Lerma 🇵🇭 on X: @JochenReiser @Kidney_Int @goKDIGO See this study (ca. 2014) by @raja_1980 from @NDTsocial In patients with FSGS who had complete remission (CR), TAC dose was reduced to
Edgar V. Lerma 🇵🇭 on X: What are the relevant publications that
Edgar V. Lerma 🇵🇭 on X: @JochenReiser @Kidney_Int @goKDIGO See this study (ca. 2014) by @raja_1980 from @NDTsocial In patients with FSGS who had complete remission (CR), TAC dose was reduced to
Edgar Lerma on LinkedIn: #kdigoadpkd #nephpearls
Edgar V. Lerma 🇵🇭 on X: @JochenReiser @Kidney_Int @goKDIGO See this study (ca. 2014) by @raja_1980 from @NDTsocial In patients with FSGS who had complete remission (CR), TAC dose was reduced to
Edgar V. Lerma 🇵🇭 on X: Integrated approach to interpret
Edgar V. Lerma 🇵🇭 on X: @JochenReiser @Kidney_Int @goKDIGO See this study (ca. 2014) by @raja_1980 from @NDTsocial In patients with FSGS who had complete remission (CR), TAC dose was reduced to
Edgar V. Lerma 🇵🇭 on X: .@goKDIGO Glomerular Diseases Guideline
Edgar V. Lerma 🇵🇭 on X: @JochenReiser @Kidney_Int @goKDIGO See this study (ca. 2014) by @raja_1980 from @NDTsocial In patients with FSGS who had complete remission (CR), TAC dose was reduced to
Edgar V. Lerma 🇵🇭 on X: What are the relevant publications that
Edgar V. Lerma 🇵🇭 on X: @JochenReiser @Kidney_Int @goKDIGO See this study (ca. 2014) by @raja_1980 from @NDTsocial In patients with FSGS who had complete remission (CR), TAC dose was reduced to
Edgar V. Lerma 🇵🇭 on X: FSGS ca. 2021 from @Kidney_Int @goKDIGO
für dich empfohlen
Sie können auch mögen

© 2014-2024 fenasera.org.br. Inc. or its affiliates.